Earnings Labs
Supernus Pharmaceuticals, Inc. logo

Supernus Pharmaceuticals, Inc. (SUPN) Earnings

NASDAQ·Healthcare·Drug Manufacturers - Specialty & Generic

$48.70

-1.54%

Mkt Cap $2.87B

Next Earnings

In 6 days

Tue, May 5, 2026

EPS Estimate

$0.26

2 analysts

Revenue Estimate

$193.14M

Last quarter: beat by +228.57% on EPS, +8.41% on revenue.

EPS — Estimate vs Actual

Mkt Cap

$2.87B

P/E

Fwd P/E

25.99

P/S

3.99

Rev TTM

EPS TTM

-$0.68